- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: BI 691751 high dose
Total 1681 results
-
Lundbeck LLCCompletedEpilepsy | Epilepsy, Generalized | SeizuresUnited States
-
WestVac Biopharma Co., Ltd.Not yet recruiting
-
Cerevel Therapeutics, LLCCompletedPanic DisorderNetherlands
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic Obstructive
-
Ottawa Hospital Research InstituteRecruitingPatent Ductus Arteriosus After Premature BirthCanada
-
Helwan UniversityActive, not recruitingPost Operative Atrial FibrillationEgypt
-
Kobe UniversityCompletedCoronary Artery Disease Progression
-
Boehringer IngelheimCompleted
-
Boehringer IngelheimCompleted
-
Lexicon PharmaceuticalsCompleted
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
Children's Hospital Medical Center, CincinnatiTerminatedRecurrent Adult Lymphoblastic Lymphoma | Refractory Acute Lymphoblastic Leukemia | Refractory Lymphoblastic Lymphoma | Relapsed Lymphoblastic LeukemiaUnited States
-
Seoul National University HospitalWyeth is now a wholly owned subsidiary of PfizerUnknown
-
MorphoSys AGClinigen Healthcare LtdApproved for marketing
-
Gregory DanielsRecruitingMelanoma Stage Iv | Renal Cell Carcinoma, MetastaticUnited States
-
Fatebenefratelli and Ophthalmic HospitalCompletedPercutaneous Coronary Intervention | Angioplasty, Balloon, Coronary | Arteriosclerosis, Coronary | Coronary Angioplasty, Transluminal BalloonItaly
-
University of BolognaCompletedAcute Myocardial InfarctionItaly
-
Boehringer IngelheimCompleted
-
Yonsei UniversitydotterRecruitingCoronary Artery Disease | DyslipidemiasKorea, Republic of
-
Anhui Medical UniversityUnknownSelf Efficacy | Drug ToxicityChina
-
Boehringer IngelheimCompleted
-
French Innovative Leukemia OrganisationAmgenCompleted
-
Boehringer IngelheimCompleted
-
Tanta UniversityRecruitingHemorrhagic Shock | Norepinephrine | Hypotensive ResuscitationEgypt
-
Morten Hostrup, PhDRecruiting
-
JDP Therapeutics, Inc.Algorithme Pharma IncCompleted
-
Yale UniversityCompletedNicotine Dependence, Other Tobacco ProductUnited States
-
Menoufia UniversityCompletedCesarean Section; ShiveringEgypt
-
University of PennsylvaniaNational Institute on Drug Abuse (NIDA)Completed
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Bulgaria, Germany, Guatemala, Hungary, Israel, Latvia, Mexico, Philippines, Portugal, South Africa, Ukraine
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedAutistic Disorder | AutismUnited States
-
Bond Avillion 2 Development LPCompletedAsthmaUnited States, Germany, Ukraine, Serbia, Czechia, Argentina, Slovakia
-
The Jackson LaboratoryNational Institute of Allergy and Infectious Diseases (NIAID); University of... and other collaboratorsRecruitingAging | Influenza Vaccine | Vaccine Response | Dendritic CellUnited States
-
Samsung Medical CenterUnknown
-
Boehringer IngelheimCompleted
-
Daniel BenjaminPediatric Pharmacology Research Units NetworkCompletedCandidiasisUnited States
-
Boehringer IngelheimCompleted
-
Federal University of ParaíbaUnknown
-
Anhui Provincial HospitalNot yet recruitingHigh Titers of Anti-HLA Antibody (MFI ≥5000)China
-
Sanofi Pasteur, a Sanofi CompanyCompleted
-
Supernus Pharmaceuticals, Inc.Solstice NeurosciencesNot yet recruiting
-
Johns Hopkins UniversityNational Institute on Drug Abuse (NIDA)CompletedSleep Disturbance | Opioid Dependence | Opioid WithdrawalUnited States
-
Tulane University Health Sciences CenterWithdrawnInsulin Resistance | Endothelial Dysfunction
-
Noven Pharmaceuticals, Inc.CompletedSchizophreniaUnited States
-
Mitsubishi Tanabe Pharma CorporationTerminated
-
Iroko Pharmaceuticals, LLCCompletedPain, PostoperativeUnited States
-
Michael A. Rogawski, MD, PhDUnited States Department of DefenseCompletedTraumatic Brain Injury | Posttraumatic EpilepsyUnited States
-
Boehringer IngelheimPfizerCompletedAsthmaUnited States, Argentina, Australia, Belgium, Brazil, Canada, Czech Republic, Germany, Guatemala, Hungary, Latvia, Lithuania, Poland, Romania, Russian Federation, Slovakia, Ukraine